‘Modified risk’ VLN cigarettes ready for launch in ‘major metropolitan market’

22nd Century Group is to announce its full year results on 1st March, after confirming the launch of its two low-nicotine cigarettes as modified risk tobacco products, following the US Food and Drug Administration (FDA)’s marketing authorisation in December.

The New York-based company said a the pilot market launch of its VLN products, including a menthol cigarette, would begin in an unnamed “major metropolitan market”, with expansion to a full nationwide marketing and distribution launch soon after.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Pablo Sharrock
+34 722 642 678
Email Pablo